WC | Sens. % | Spec.% | PPV % | NPV % | Youden | Prevalence MetSc (%) | Odds ratiod | |
---|---|---|---|---|---|---|---|---|
Value | 95% CI | |||||||
Men | ||||||||
 90a | 77.9 | 53.3 | 74.9 | 57.4 | 0.3119 | 54.1 | 1.26 | 1.22–1.30 |
 91 | 74.8 | 57.6 | 76.0 | 56.0 | 0.3241 | 52.9 | 1.38 | 1.32–1.44 |
 92 | 71.2 | 61.2 | 76.7 | 54.3 | 0.3245 | 51.5 | 1.50 | 1.42–1.59 |
 93 | 67.7 | 64.5 | 77.4 | 52.7 | 0.3220 | 50.1 | 1.64 | 1.53–1.76 |
 94b | 63.9 | 67.2 | 77.7 | 50.9 | 0.3110 | 48.6 | 1.78 | 1.64–1.93 |
 95 | 59.7 | 70.8 | 78.5 | 49.5 | 0.3048 | 47.0 | 1.93 | 1.76–2.12 |
 96 | 56.0 | 73.6 | 79.1 | 48.3 | 0.2954 | 45.7 | 2.09 | 1.88–2.32 |
 97 | 52.2 | 76.6 | 80.0 | 47.2 | 0.2884 | 44.3 | 2.25 | 2.01–2.52 |
 98 | 48.4 | 80.0 | 81.2 | 46.4 | 0.2836 | 43.0 | 2.42 | 2.14–2.73 |
 99 | 44.8 | 82.8 | 82.3 | 45.5 | 0.2755 | 41.8 | 2.59 | 2.27–2.94 |
 100 | 40.9 | 85.0 | 83.0 | 44.5 | 0.2593 | 40.4 | 2.76 | 2.41–3.15 |
 101 | 37.9 | 86.5 | 83.4 | 43.8 | 0.2444 | 39.6 | 2.93 | 2.56–3.35 |
 102 | 34.3 | 88.1 | 83.8 | 42.8 | 0.2244 | 38.4 | 3.10 | 2.71–3.55 |
Women | ||||||||
 80ab | 87.4 | 41.9 | 55.3 | 80.2 | 0.2932 | 40.5 | 1.11 | 1.09–1.12 |
 81 | 84.8 | 46.4 | 56.5 | 78.8 | 0.3122 | 39.8 | 1.22 | 1.19–1.25 |
 82 | 82.4 | 50.3 | 57.6 | 77.6 | 0.3265 | 39.0 | 1.34 | 1.30–1.39 |
 83 | 79.4 | 53.9 | 58.6 | 76.0 | 0.3322 | 38.1 | 1.48 | 1.42–1.54 |
 84 | 77.2 | 57.6 | 59.9 | 75.5 | 0.3478 | 37.6 | 1.62 | 1.55–1.70 |
 85 | 74.3 | 61.4 | 61.3 | 74.4 | 0.3574 | 36.6 | 1.77 | 1.68–1.87 |
 86 | 70.8 | 65.1 | 62.5 | 73.0 | 0.3589 | 35.6 | 1.93 | 1.83–2.05 |
 87 | 67.5 | 68.2 | 63.5 | 71.8 | 0.3566 | 34.7 | 2.10 | 1.98–2.24 |
 88 | 64.1 | 71.1 | 64.5 | 70.6 | 0.3513 | 33.7 | 2.28 | 2.14–2.44 |
 89 | 60.5 | 73.6 | 65.4 | 69.4 | 0.3419 | 32.6 | 2.47 | 2.30–2.66 |
 90 | 57.1 | 76.2 | 66.4 | 68.4 | 0.3333 | 31.6 | 2.67 | 2.47–2.89 |